2024 Presentations

CONCERT Network – Friday – Capitol 2

• Sponsors
• Chen Evan – Immune Effector Therapies for Lymphoid Leukemia
• Kumaran Muthu – Creating a Partnership Between Academia and Community Practices in Delivering Cellular Therapies for Hematologic Malignancies
• Peters Brooke – Updating Your Therapeutic Armamentarium – An Update to Operating Procedures and Personnel
• Phillips Tycel – Understanding and Managing Your Patients with Current Immune Effector Therapeutic Options in Lymphomas
• Usmani Saad – Emerging and Cellular Therapeutic Options for Multiple Myeloma- Understanding Your Immune Effector Therapeutic Options in Multiple Myeloma

D.R.I.V.E. Initiative – Friday – Capitol 2

• Sponsors
• Anderson Kenneth & Tefferi Ayalew & LunningMatthew- How We do it- BEYOND TALK- Improving Accrual of Minorities to Clinical Trials
• Birhiray Maya & RangerSam – DRIVEing the Next Generation of Medical Researchers
• Birhiray Ruemu – Promoting Clinical Research Diversity – DRIVEing BEYOND The Indianapolis Black Paper
• Davis Audrey – Advocating Alongside and Not Just About- Community Outreach and Engagement
• Gormley Nicole – FDORA – How to Wear a FDORA- Implications for Today’s Clinical Researchers and the Pharmaceutical Industry
• Jeames Sanford – Promoting DEIA in Oncology Clinical Oncology Research- The Role of Major Medical Societies
• Ridley-Merriweather Kathi – Five Simple Steps
• Shobe Brian – Educating Minority Populations- The Alliance of Community Organizations and Medicine
• Winkfield Karen – A Clinical Investigator’s Approach to Promoting DEIA in Oncology Clinical Research

Symposium – Saturday – Grand 4&5

• Sponsors
• Anderson Kenneth Introduction
• Anderson Kenneth – Emerging and Current Treatment of Multiple Myeloma
• Ansell Stephen Introduction
• Ansell Stephen – Emerging and Current Treatment for Hodgkin Lymphoma
• Birhiray Ruemu – Hematologic Malignancies Townhall
• Birhiray Ruemu – State of the Art 2024 Emerging Therapies in Hematologic Malignancies
• Brodsky Robert Introduction
• Brodsky Robert – T. Howard Lee Keynote Lecture: The Emerging Story of Complementopathies: Treatment of Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia
• Childs Richard Introduction
• Childs Richard – Hematopoietic Transplantation and Cellular Therapies- When to Refer and Managing Complications
• Erba Harry Introduction
• Erba Harry – Treatment of Acute Myeloid Leukemias- Managing the AML Patient When Transplant is Not an Option
• Gertz Morie Introduction
• Gertz Morie – Managing Amyloidosis – How We Diagnose and Treat
• Hillman Peter Introduction
• Hillmen Peter – Annual Steven Coutre Chronic Lymphocytic Leukemia Memorial Lecture: Targeted Therapies in Hematologic Disorders Treatment Considerations for Initial Therapy of Chronic Lymphocytic Leukemia
• Kessler Craig Introduction
• Kessler Craig – Classical Hematology- Managing Disorders of Bleeding and Clotting
• Komrokji Rami Introduction
• Komrokji Rami – Current, Emerging and Targeted Therapies for the Treatment of Relapsed and Refractory AML
• Larson Richard Introduction
• Larson Richard – Controversies in the Management of Chronic Myeloid Leukemia – How I Approach Patients in 2024
• Phillips Tycel Introduction
• Phillips Tycel – Immune Effector Cell Therapy for Lymphoid Malignancies – What to Do and Know in Community Oncology Practice
• Rampal Raajit Introduction
• Rampal Raajit – Myelofibrosis, Philadelphia Chromosome Negative Myeloproliferative Neoplasms and Systemic Mastocytosis
• Shet Arun Introduction
• Shet Arun – BEYOND PAIN- Improving the Outcomes of Sickle Cell Disease with Therapeutics and Cellular Therapy in 2024
• Smith Sonali Introduction
• Smith Sonali – Current Advances in the Treatment of Aggressive B and T Cell Lymphomas
• Stone Richard Introduction
• Stone Richard – Removing Bad Humor and Targeting Aberrant Signaling – Treatment Strategies of Myelodysplastic Syndromes and Acute Lymphoblastic Leukemia
• Tefferi Ayalew Introduction
• Tefferi Ayalew – Evaluation, Diagnosis and Prognostication and Emerging Therapies for Myeloproliferative Neoplasms
• Treon Steven Introduction
• Treon Steven – Waldenstrom’s Macroglobulinemia- Approaching the Newly Diagnosed and Relapsed Patient
• Usmani Saad Introduction
• Usmani Saad – Immune Effector Cell Therapy for Multiple Myeloma- What to Do and Know in Community Oncology Practice
• Williams Michael Introduction
• Williams Michael – When Not to Watch and Wait- Emerging Strategies in the Treatment of Indolent Lymphoma and Mantle Cell Lymphoma
• Woyach Jennifer Introduction
• Woyach Jennifer – Chronic Lymphocytic Leukemia- Evaluating and Therapeutic Approaches for the Management of the Relapsed-Refractory Patient

Nursing & Allied Providers – Saturday – Capitol 2

• Sponsors
• Garofalo Sandra – Management of Long-Term Survivors of Hematologic Malignancies
• Kessler Craig – Managing Disorders of the Benign Hematology
• Komrokji Rami – Current and Emerging Therapies for Acute Myeloid Leukemias and Myelodysplastic Syndromes
• Larson Richard – How I treat Chronic Myeloid Leukemia – Understanding and Addressing
• Orbaugh Kristi – Recognizing Toxicities of Oral Oncolytics in the Management of Hematologic Malignancies
• Reeves David – Understanding and Managing Immune Effector Toxicities in Hematologic Toxicities
• Tefferi Ayalew – Current Approaches in the Treatment of Myeloproliferative Neoplasms
• Treon Steven – Emerging and Current Treatment of Waldenstrom’s Macroglobulinemia
• Usmani Saad – Understanding the Diagnosis and Treatment of Plasma Cell Disorders and Amyloidosis